SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on March 25, 2025, reporting an event that occurred on March 24, 2025. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding stock listing requirements.
Material Changes
The primary material change is the Company's successful restoration of full compliance with Nasdaq listing standards. Previously, on October 18, 2024, the Company received notice of non-compliance with Nasdaq Listing Rule 5550(b), which requires either $35 million in market value of listed securities or $2.5 million in stockholders' equity. The Company was granted an exception period through March 7, 2025, to regain compliance. On March 6, 2025, the Company submitted evidence of compliance with the stockholders' equity requirement, and on March 24, 2025, Nasdaq confirmed the Company has met the qualifications to continue listing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of new risks or contingencies beyond the resolution of the prior listing deficiency. The unusual item addressed is the temporary delisting risk which has now been resolved.
Key Facts for Investor Verification
- Confirm the Company's current stockholders' equity exceeds the $2.5 million threshold required by Nasdaq Listing Rule 5550(b).
- Verify the current trading status of BSGM on the Nasdaq Capital Market to ensure no further interruptions.
- Review the Company's most recent 10-Q or 10-K filings to assess the financial position that enabled compliance with the equity rule.
- Monitor for any future notices from Nasdaq regarding market value of listed securities, as the Company may still be below the $35 million market value alternative.